News Article
CMA private dentistry review – why there’s no need for investors to panic
For investors in UK healthcare, private dentistry has moved firmly onto the risk radar.
The Competition and Markets Authority’s review of the £8.4bn sector is set to test assumptions around pricing, competition, and long-term value creation.
In our latest insight piece, Candesic senior partner Marc Kitten and head of content David Farbrother cut through the noise to assess:
• Why the review is happening now
• What signals we can take from similar interventions
• How investors and operators should be thinking about risk and opportunity
The headline? This is a moment to stay informed and strategic – not reactive.
There are clear implications emerging for dealmaking, operational models, and how platforms position themselves in a more scrutinised environment. Those who get ahead of the curve will be best placed to navigate what comes next.
If you’re active in healthcare or private equity, this is one to watch closely.
To read the full report and our detailed perspective, simply click the link.
Want to know more? Email the author [email protected] or reach out to him on LinkedIn.
